Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions

May 09, 2019 12:33 JST

Source: Eisai

TOKYO, May 09, 2019 - (JCN Newswire) - Eisai Co., Ltd. and Allm Inc. have entered into a capital and business alliance agreement for ICT digital health solutions in various areas as well as regional medical treatment and care. Under this capital and business alliance, the two companies will collaborate on information provision to patients and healthcare professionals as well as development and provision of digital health solutions in regional medical treatment cooperation and comprehensive community care by extensively utilizing Allm's ICT systems for medical treatment and care. By applying Allm's experience in medical ICT systems to the "Dementia Ecosystem" that Eisai aims to establish, the two companies will thoroughly promote the utilization of IoT, big data and AI technologies in the health care area and provide new value for patients under the Fourth Industrial Revolution.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), promoting various kinds of digitalization such as the analysis of big data including real world data for the development of diagnostic methods and the provision of solutions in addition to creating next-generation treatment primarily in "neurology" and "oncology" that are Eisai's therapeutic areas of focus. Especially in the area of dementia, Eisai aims to establish the "Eisai Dementia Platform" by actively utilizing external big data and genomic data in addition to Eisai's own experience, know-how, and clinical data as well as build the "Dementia Ecosystem" by collaborating with partners such as other pharmaceutical companies, governments, medical organizations, care facilities, diagnostic developing companies, IT companies and insurance companies. Eisai thus aims to deliver novel benefits to patients with dementia and their families.

As "a company supporting all medicines (All Medical)", Allm upholds "Shaping Healthcare" as its corporate message, and provides services making contributions to the creation of global, social welfare design through IT technology. As a venture company specialized in medicine and healthcare, Allm is engaged in the development of programs for medical devices and provides "Team" comprehensive community care application and "MySOS" personal health record app. Currently operating in 12 countries, the company internationally provides approximately 1,700 medical/nursing institutions with ICT systems for medicine and nursing. In particular, the "Join" communication app for communication among healthcare professionals has become Japan's first medical device program which was made eligible for national health insurance by the Central Social Insurance Medical Council of the Japanese Ministry of Heath, Labor and Welfare.

Through these efforts to coordinate on the provision of healthcare solutions using ICT and the establishment of ecosystems in the area of dementia and others, Eisai and Allm are working to solve issues in regional medical treatment and care, and therefore contribution to the realization of well-being.

About Allm Inc.

As a "company supporting all medicines (All Medical)" upholding "Shaping Healthcare" as its corporate message, Allm provides mobile ICT solutions in the area of medicine and welfare. The company also proactively approaches global deployment of medical ICT business including the "Join" app for communication among healthcare professionals, providing solutions in 12 countries as a Japanese medical ICT company.

For more information about Allm Inc., please visit https://www.allm.net.

Contact:

Allm Inc.
Group Strategy Office 
Tel：03-6418-3010

Eisai Co., Ltd.
Public Relations Department 
Tel：03-3817-5120

Source: Eisai
Sectors: BioTech

Related Press Release

Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan

June 02 2025 16:46 JST

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China

May 28 2025 16:45 JST

Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025

May 21 2025 14:00 JST

Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro

May 16 2025 16:21 JST

Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star

April 30 2025 13:17 JST

Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union

April 18 2025 15:52 JST

Eisai to Divest Rights for Pariet in China to Peak Pharma

April 01 2025 12:15 JST

World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards

March 25 2025 16:28 JST

Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace

March 25 2025 11:21 JST

Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time

March 10 2025 19:24 JST

More Press release >>

Latest Press Release

DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture
Jul 04, 2025 16:20 JST

MHIET Launches 450kW Gas Cogeneration System Capable of Hydrogen Co-Firing
Jul 04, 2025 15:13 JST

Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures
Jul 04, 2025 13:25 JST

Fujitsu to implement store monitoring solution for METRO Inc. in Canada, enhancing operational efficiency and policy compliance
Jul 04, 2025 13:19 JST

Fujitsu to develop ETF trading platform based on TSE's CONNEQTOR and provide it to Australian Securities Exchange
Jul 03, 2025 11:14 JST

Mitsubishi Motors Launches the All-New Grandis for the European Market
Jul 02, 2025 12:10 JST

Valuufy partners with Mainichi Future Creation Lab, Supporting New Approaches to Business Sustainability
Jul 02, 2025 12:00 JST

Fujitsu launches solution to enhance customers' global supply chain resilience
Jul 02, 2025 11:32 JST

MHI Receives Order to Supply Four Circulating Water Pumps for Units 5 and 6 of Sanmen Nuclear Power Plant in China Under Collaboration with Dongfang Electric Machinery
Jul 02, 2025 11:30 JST

Multi-purpose Arena in Odaiba Aomi Area TOYOTA ARENA TOKYO Construction Completed
Jul 01, 2025 22:56 JST

1Finity, a Fujitsu company, commences operations and reveals brand identity
Jul 01, 2025 22:53 JST

MHI Thermal Systems Begins Field Test of Jointly Developed "Surplus Renewable Energy Absorption and Release System"
Jul 01, 2025 22:40 JST

Japan's Telecommunications Carriers Strengthen Disaster Response Through Collaborative Information Sharing
Jul 01, 2025 22:30 JST

JCB and Mandai Wildlife Group Deepen Partnership with exclusive discounts for JCB cardmembers
Jul 01, 2025 16:00 JST

Fujitsu provides Japan's first AI-powered cloud-based library search service
Jul 01, 2025 11:30 JST

JCB Brings Apple Pay to Cardmembers in Vietnam
Jul 01, 2025 11:15 JST

First Shipment of LNG from the LNG Canada Project
Jul 01, 2025 11:00 JST

Approval in Principle (AiP) for World's First LCO2 / Methanol Carrier
Jun 30, 2025 20:30 JST

Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier
Jun 30, 2025 20:15 JST

Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles
Jun 30, 2025 20:10 JST

More Latest Release >>